There is no single age at which every man should get his prostate checked. For most men at average risk, the conversation with a doctor about prostate cancer screening usually begins around age 50. Men at higher risk — including Black men and those with a father or brother who had prostate cancer — are generally advised to start that conversation earlier, often around age 45. The decision itself is personal, and it should follow a real discussion with a clinician, not a fixed rule.
Why Is There No Simple Age for Prostate Screening?
Prostate cancer screening is not like a blood pressure check or a cholesterol test. Two large trials changed how doctors think about it, and their results did not point in the same direction.
The European Randomized Study of Screening for Prostate Cancer found that PSA-based screening reduced deaths from prostate cancer, but the benefit was small and took many years to appear. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial in the United States did not find a statistically significant reduction in prostate cancer deaths from screening. Both trials are well known and widely cited, and the difference in their results is part of why guidance has shifted over time.
The core problem is that many prostate cancers grow so slowly they would never cause symptoms or shorten a man’s life. Finding them through screening can lead to treatment that causes real harm — incontinence, erectile dysfunction, and other side effects — for a cancer that might never have mattered. At the same time, some prostate cancers are aggressive and deadly, and finding them early can save lives. Screening tries to catch the second kind without over-treating the first. That balance is genuinely difficult, and it is why the decision is meant to be shared between a man and his doctor rather than applied uniformly.
What Actually Happens During a Prostate Check?
A prostate check is not one single test. It usually involves a conversation, a blood test, and sometimes a physical exam.
The PSA test measures prostate-specific antigen, a protein made by the prostate gland. PSA levels can rise for many reasons — prostate cancer, but also an enlarged prostate, a prostate infection, recent ejaculation, or a recent bike ride. A high PSA does not mean cancer, and a normal PSA does not rule it out.
The digital rectal exam (DRE) is a physical check in which a doctor inserts a gloved finger into the rectum to feel the prostate for lumps, hardness, or other abnormalities. A DRE can find some cancers that a PSA test might miss, but it also has limitations. Many clinicians still perform it as part of an initial evaluation, though its role in routine screening has become less central over time.
If either test raises concern, the next step may be a prostate biopsy. This involves taking small tissue samples from the prostate, usually guided by imaging, to check for cancer cells. A biopsy is the only way to confirm a prostate cancer diagnosis.
Newer tools, including MRI imaging before biopsy, have changed how some of these evaluations are done. MRI can help doctors decide whether a biopsy is needed and where to take samples. This approach is increasingly used in clinical practice, though access and protocols vary.
Who Is Considered Higher Risk for Prostate Cancer?
Some men face a higher chance of developing prostate cancer, and that affects when screening conversations should start.
- Age. Risk rises sharply after age 50. Most prostate cancers are found in men over 65.
- Race and ethnicity. Black men in the United States are more likely to develop prostate cancer and more likely to die from it than white men. The reasons are not fully understood and likely involve a mix of biological, social, and healthcare access factors.
- Family history. Having a father or brother with prostate cancer increases a man’s risk. The more relatives affected, and the younger they were when diagnosed, the higher the risk tends to be.
- Genetic factors. Certain inherited gene mutations, including BRCA1 and BRCA2, are linked to higher prostate cancer risk. These same mutations are better known for their role in breast and ovarian cancer.
For men in these higher-risk groups, many clinical guidelines suggest starting the screening conversation around age 45, or even earlier in some cases. This is a general direction, not a universal rule, and individual circumstances matter.
What Do Major Guidelines Actually Say?
Different organizations have issued different recommendations, and they do not fully agree. That disagreement is real and reflects the genuine uncertainty in the evidence.
The U.S. Preventive Services Task Force recommends that men aged 55 to 69 make an individual decision about PSA-based screening after talking with their doctor. For men 70 and older, the task force recommends against routine PSA screening. This is a Grade C recommendation for the 55–69 group, meaning the net benefit is small and the decision should be individualized.
The American Cancer Society suggests that men at average risk discuss screening with a doctor starting at age 50, and men at higher risk start at 45. It emphasizes that men should make an informed decision.
The American Urological Association recommends shared decision-making for men aged 55 to 69 and suggests that screening may begin as early as 40 to 45 for men at higher risk. It does not recommend routine screening for men under 40 or over 69 who are at average risk.
These guidelines are not identical, and they have been updated multiple times as new evidence has emerged. The common thread is that no major organization recommends screening every man at a fixed age without a conversation.
How Does a Man Decide Whether to Get Checked?
The decision comes down to weighing a small chance of benefit against a real chance of harm, and that balance depends on the individual.
Questions worth discussing with a doctor include:
- What is my personal risk based on my age, race, and family history?
- What are the possible benefits of screening for someone like me?
- What are the possible harms, including false positives, unnecessary biopsies, and treatment side effects?
- If cancer is found, what are my options for monitoring versus treating it?
- How often would I need to be tested if I decide to screen?
One point that is often misunderstood: a prostate cancer diagnosis does not automatically mean immediate treatment. Many men with low-risk prostate cancer choose active surveillance, which means regular monitoring with PSA tests, exams, and sometimes repeat biopsies, rather than surgery or radiation right away. Active surveillance is a well-established approach for low-risk disease and can help men avoid treatment side effects. It is not the same as doing nothing — it is a structured monitoring plan.
What About Men Over 70?
For men over 70 who are at average risk, most major guidelines do not recommend routine PSA screening. The reasoning is that the potential benefit of finding a slow-growing cancer diminishes with age, while the risks of treatment and the stress of a diagnosis remain.
This does not mean a man over 70 should never discuss prostate health with his doctor. If symptoms appear — such as difficulty urinating, blood in the urine, or bone pain — those should be evaluated regardless of age. The guideline recommendation against routine screening applies to men without symptoms who are at average risk.
Men over 70 who are in excellent health and have a long life expectancy may still choose to screen after a discussion with their doctor. The decision is individual, and age alone does not settle it.
What Symptoms Should Prompt a Doctor Visit?
Prostate cancer often causes no symptoms in its early stages. When symptoms do appear, they can include:
- Difficulty starting or stopping urination
- Weak or interrupted urine flow
- Frequent urination, especially at night
- Blood in the urine or semen
- Painful ejaculation
- Pain in the hips, back, or pelvis that does not go away
These symptoms can also be caused by conditions that are not cancer, including benign prostatic hyperplasia (an enlarged prostate) and prostatitis (inflammation or infection of the prostate). Having these symptoms does not mean a man has cancer, but they are worth evaluating. Any man with these symptoms should see a doctor, regardless of his age or screening history.
Frequently Asked Questions
At what age should a man start prostate screening?
Most guidelines suggest men at average risk begin discussing screening around age 50, while higher-risk men — including Black men and those with a family history — may start around age 45. The decision should follow a conversation with a doctor, not a fixed age.
Is a PSA test enough to detect prostate cancer?
No. A PSA test can be elevated for reasons other than cancer, and it can miss some cancers. A biopsy is the only way to confirm a prostate cancer diagnosis.
Can prostate cancer be monitored without treatment?
Yes. Active surveillance is a well-established option for low-risk prostate cancer and involves regular monitoring rather than immediate surgery or radiation. It is not the same as ignoring the cancer.
Should men over 70 still get their prostate checked?
Most major guidelines do not recommend routine PSA screening for men over 70 who are at average risk and have no symptoms. Men with urinary symptoms or other concerns should still see a doctor.
